BioCentury | Feb 6, 2021
Deals

Feb. 5 Quick Takes: Veracyte taking out Decipher in cancer dx merger; plus V-Bio, Branson-and-Me, Elucidata, Osel

...$25 million into a $250 million PIPE to fund the deal and are joined by Fidelity Management & Research Co....
BioCentury | Jan 20, 2021
Product Development

Trucode reboots as Vera with Abingworth-led $80M series C, disease-modifying therapy for orphan kidney disease

...head, inflammation/respiratory.Also participating in the company’s series C were new investors Sofinnova Investments, Longitude Capital, Fidelity Management & Research Co....
BioCentury | Jan 5, 2021
Finance

Immuneering, Terns, Ikena raise crossover rounds as IPO queue stands to grow again

...Atlas and OrbiMed, investors in Ikena’s round included Fidelity Management & Research Co....
BioCentury | Nov 12, 2020
Finance

Nov. 11 Quick Takes: Adagio raises $80M for COVID-19 antibody; plus venture investments for Congenica, CoImmune, Trailhead, Doer Biologics, Protomer and more

...series B round led by GV, with backing from existing investors Polaris Partners, Mithril Capital, Fidelity Management & Research Co....
BioCentury | Nov 10, 2020
Finance

Nov. 9 Quick Takes: Biogen sheds $14B in value; plus Ambrx’s 200M round, Decibel’s series D and more

...immunotherapies made using synthetic DNA to incorporate non-native amino acids into proteins. New investors included Fidelity Management & Research Co....
BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...round led by OrbiMed Advisors and an undisclosed existing investor, with participation from new investor Fidelity Management & Research Co....
BioCentury | Aug 6, 2020
Finance

Led by AveXis vets, Taysha adds dry powder ahead of first clinical trials for CNS gene therapy pipeline

...therapy programs into the clinic and build a commercially scalable GMP manufacturing facility. Led by Fidelity Management & Research Co....
BioCentury | Jul 22, 2020
Finance

July 21 Quick Takes: Royalty to reap risdiplam royalties; plus CureVac, Antengene, Citrine, Verona, Novartis, Amicus, Aslan, SAB, Gain

...Shanghai cancer company Antengene Corp. raised $97 million in a series C round led by Fidelity Management & Research Co....
BioCentury | Jul 16, 2020
Emerging Company Profile

Adimab spinout aims for neutralizing mAbs more effective than coronavirus vaccines

...newco aims to produce up to 60 million doses per year from one 100,000-liter reactor. Fidelity Management & Research Co....
BioCentury | Jul 8, 2020
Finance

Crossovers pile into $110M series B as Vor heads into the clinic

...program into the clinic. RA Capital led the round, which saw participation from new investors Fidelity Management & Research Co....
Items per page:
1 - 10 of 25
BioCentury | Feb 6, 2021
Deals

Feb. 5 Quick Takes: Veracyte taking out Decipher in cancer dx merger; plus V-Bio, Branson-and-Me, Elucidata, Osel

...$25 million into a $250 million PIPE to fund the deal and are joined by Fidelity Management & Research Co....
BioCentury | Jan 20, 2021
Product Development

Trucode reboots as Vera with Abingworth-led $80M series C, disease-modifying therapy for orphan kidney disease

...head, inflammation/respiratory.Also participating in the company’s series C were new investors Sofinnova Investments, Longitude Capital, Fidelity Management & Research Co....
BioCentury | Jan 5, 2021
Finance

Immuneering, Terns, Ikena raise crossover rounds as IPO queue stands to grow again

...Atlas and OrbiMed, investors in Ikena’s round included Fidelity Management & Research Co....
BioCentury | Nov 12, 2020
Finance

Nov. 11 Quick Takes: Adagio raises $80M for COVID-19 antibody; plus venture investments for Congenica, CoImmune, Trailhead, Doer Biologics, Protomer and more

...series B round led by GV, with backing from existing investors Polaris Partners, Mithril Capital, Fidelity Management & Research Co....
BioCentury | Nov 10, 2020
Finance

Nov. 9 Quick Takes: Biogen sheds $14B in value; plus Ambrx’s 200M round, Decibel’s series D and more

...immunotherapies made using synthetic DNA to incorporate non-native amino acids into proteins. New investors included Fidelity Management & Research Co....
BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...round led by OrbiMed Advisors and an undisclosed existing investor, with participation from new investor Fidelity Management & Research Co....
BioCentury | Aug 6, 2020
Finance

Led by AveXis vets, Taysha adds dry powder ahead of first clinical trials for CNS gene therapy pipeline

...therapy programs into the clinic and build a commercially scalable GMP manufacturing facility. Led by Fidelity Management & Research Co....
BioCentury | Jul 22, 2020
Finance

July 21 Quick Takes: Royalty to reap risdiplam royalties; plus CureVac, Antengene, Citrine, Verona, Novartis, Amicus, Aslan, SAB, Gain

...Shanghai cancer company Antengene Corp. raised $97 million in a series C round led by Fidelity Management & Research Co....
BioCentury | Jul 16, 2020
Emerging Company Profile

Adimab spinout aims for neutralizing mAbs more effective than coronavirus vaccines

...newco aims to produce up to 60 million doses per year from one 100,000-liter reactor. Fidelity Management & Research Co....
BioCentury | Jul 8, 2020
Finance

Crossovers pile into $110M series B as Vor heads into the clinic

...program into the clinic. RA Capital led the round, which saw participation from new investors Fidelity Management & Research Co....
Items per page:
1 - 10 of 25